Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, September 2 2015 6:36am ET - U.S. Markets open in 2 hours and 54 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Diagnostic Substances News
Latest News
Tuesday, Sep 1, 2015
·Vermillion Announces Launch of New Website in Conjunction with Ovarian Cancer Awareness Month
PR Newswire - Tue 4:01 pm ET
·AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire - Tue 4:00 pm ET
Thursday, Aug 27, 2015
·Quidel to Present at 10th Annual Wells Fargo Healthcare Conference
Marketwire - Thu Aug 27
·Neogen acquires U.K.-based Lab M Holdings
PR Newswire - Thu Aug 27
Monday, Aug 24, 2015
·AMAG Pharmaceuticals Appoints Joseph Vittiglio as General Counsel and Secretary
GlobeNewswire - Mon Aug 24
Thursday, Aug 20, 2015
·Oxford Immunotec to Present at the Baird 2015 Healthcare Conference
GlobeNewswire - Thu Aug 20
·Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'
at TheStreet.com - Thu Aug 20
Wednesday, Aug 19, 2015
·Quidel Announces Changes to Board of Directors
Marketwire - Wed Aug 19
·Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'
at TheStreet.com - Wed Aug 19
·CNS Response Presents PEER Findings at Military Research Conference
GlobeNewswire - Wed Aug 19
·Vermillion Announces Key Medical Policy Coverage for OVA1® Test
PR Newswire - Wed Aug 19
·Approval for 'female Viagra' raises questions about patient power
at FT.com - Wed Aug 19
Tuesday, Aug 18, 2015
·U.S. FDA approves 'female Viagra' with strong warning
Reuters - Tue Aug 18
·Palatin Technologies Supports FDA's Approval of the First-Ever Treatment for Female Sexual Dysfunction
PR Newswire - Tue Aug 18
·FDA Approves Addyi (Flibanserin), 'A Milestone Moment' In Women's Health
at Forbes.com - Tue Aug 18
·Why Biotech AMAG Pharma Is Worth $80 Now
- Tue Aug 18
Monday, Aug 17, 2015
·What the Cord Blood Registry Buyout Really Adds to AMAG
- Mon Aug 17
·GTCR Completes Sale of Cord Blood Registry to AMAG Pharmaceuticals
Business Wire - Mon Aug 17
·AMAG Pharmaceuticals Completes Acquisition of Cord Blood Registry
GlobeNewswire - Mon Aug 17
·Meridian Bioscience Elects Catherine Sazdanoff and John McIlwraith to the Board of Directors
Business Wire - Mon Aug 17
More Latest News...
Sponsor Results
Applied Waterjet
Precision Waterjet Cutting Perfect Parts, No Surprises
www.getwaterjet.com
Manufacturing Equipment
Complex manufacturing systems that make your line run smoother.
www.invotec.com
Medical Equipment Shipper
Complete Shipping Services For Medical Equipment Shippers
www.moveit.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?